Syntheses and in vitro biological activity of some derivatives of C-9154 antibiotic.

International Journal of Medicinal Chemistry Pub Date : 2012-01-01 Epub Date: 2012-11-25 DOI:10.1155/2012/782058
Isaac Asusheyi Bello, George Iloegbulam Ndukwe, Joseph Olorunju Amupitan, Rachael Gbekele Ayo, Francis Oluwole Shode
{"title":"Syntheses and in vitro biological activity of some derivatives of C-9154 antibiotic.","authors":"Isaac Asusheyi Bello,&nbsp;George Iloegbulam Ndukwe,&nbsp;Joseph Olorunju Amupitan,&nbsp;Rachael Gbekele Ayo,&nbsp;Francis Oluwole Shode","doi":"10.1155/2012/782058","DOIUrl":null,"url":null,"abstract":"<p><p>In our continued attempts at designing new antibiotics based on the structure of the C-9154 antibiotic, to simultaneously improve activity and lower toxicity, an analogue to the C-9154 antibiotic and six derivatives of this analogue were synthesized. The approach was to significantly reduce the polarity of the synthesized analogue in the derivatives to achieve increased permeability across cell membranes by conversion of the highly polar carboxylic group to an ester functional group. The compounds were synthesized using a two-step reaction which involved an additional reaction between benzyl amine and maleic anhydride and then conversion of the terminal carboxylic acid functional group to an ester functional group using a thionyl chloride mediated esterification reaction. The compounds were fully characterized using Infrared, GC-MS, and 1D and 2D NMR experiments. The in vitro biological activity of the compounds showed that the derivatives were more active than the analogues as was anticipated with minimum inhibitory concentration in the range 0.625-5 μg/mL. The analogue had minimum inhibitory concentration in the range 2.5-10 μg/mL. These values are significantly better than that obtained for the original C-9154 antibiotic which had activity in the range 10->100 μg/mL. </p>","PeriodicalId":14082,"journal":{"name":"International Journal of Medicinal Chemistry","volume":"2012 ","pages":"782058"},"PeriodicalIF":0.0000,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2012/782058","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Medicinal Chemistry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2012/782058","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2012/11/25 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 4

Abstract

In our continued attempts at designing new antibiotics based on the structure of the C-9154 antibiotic, to simultaneously improve activity and lower toxicity, an analogue to the C-9154 antibiotic and six derivatives of this analogue were synthesized. The approach was to significantly reduce the polarity of the synthesized analogue in the derivatives to achieve increased permeability across cell membranes by conversion of the highly polar carboxylic group to an ester functional group. The compounds were synthesized using a two-step reaction which involved an additional reaction between benzyl amine and maleic anhydride and then conversion of the terminal carboxylic acid functional group to an ester functional group using a thionyl chloride mediated esterification reaction. The compounds were fully characterized using Infrared, GC-MS, and 1D and 2D NMR experiments. The in vitro biological activity of the compounds showed that the derivatives were more active than the analogues as was anticipated with minimum inhibitory concentration in the range 0.625-5 μg/mL. The analogue had minimum inhibitory concentration in the range 2.5-10 μg/mL. These values are significantly better than that obtained for the original C-9154 antibiotic which had activity in the range 10->100 μg/mL.

Abstract Image

Abstract Image

Abstract Image

C-9154抗生素衍生物的合成及体外生物活性研究。
在我们基于C-9154抗生素结构设计新抗生素的持续尝试中,为了同时提高活性和降低毒性,我们合成了C-9154抗生素的类似物和该类似物的六个衍生物。该方法是通过将高极性羧基转化为酯官能团来显著降低衍生物中合成类似物的极性,从而增加细胞膜的通透性。该化合物的合成采用两步反应,即苯胺和马来酸酐之间的附加反应,然后通过亚硫酰氯介导的酯化反应将末端羧酸官能团转化为酯官能团。通过红外、气相色谱-质谱、一维和二维核磁共振实验对化合物进行了表征。化合物的体外生物活性表明,衍生物的活性高于类似物,最低抑制浓度在0.625 ~ 5 μg/mL之间。该类似物的最低抑菌浓度为2.5 ~ 10 μg/mL。这些值明显优于原抗生素C-9154的活性范围在10 ~ >100 μg/mL。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
期刊介绍: International Journal of Medicinal Chemistry is a peer-reviewed, Open Access journal that publishes original research articles as well as review articles in all areas of chemistry associated with drug discovery, design, and synthesis. International Journal of Medicinal Chemistry is a peer-reviewed, Open Access journal that publishes original research articles as well as review articles in all areas of chemistry associated with drug discovery, design, and synthesis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信